drugset
drugset / Trial / NCT03175939

Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma

NCT03175939 ↗

Phase 2 Completed 263 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates whether some patients with nasopharyngeal carcinoma but with low risk of distant metastasis can be treated with only radiotherapy and concomitant chemotherapy but without additional adjuvant chemotherapy.

Timeline

Start
1998-04-01
Primary completion
2008-12-31
Completion
2014-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified 60 mg/m2 Intravenous
Background fluorouracil Small molecule 600 mg/m2 Intravenous

Indications

nasopharyngeal carcinoma